187 related articles for article (PubMed ID: 11801813)
41. [Current status of diagnosis and treatment of community-acquired pneumonia in Shanghai revealed by a questionnaire analysis].
Liu J; Zhang J; Cheng QJ; Xu JF; Jie ZJ; Jiao Y; Huang Y; Qu JM
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):288-295. PubMed ID: 29690685
[No Abstract] [Full Text] [Related]
42. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J;
BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151
[TBL] [Abstract][Full Text] [Related]
43. The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation. Australian and New Zealand practice in intensive care (ANZPIC II).
Boots RJ; Lipman J; Bellomo R; Stephens D; Heller RE
Anaesth Intensive Care; 2005 Feb; 33(1):87-100. PubMed ID: 15957698
[TBL] [Abstract][Full Text] [Related]
44. [Actualities of adults' ventilator-associated pneumonia].
Svediene S; Ivaskevicius J
Medicina (Kaunas); 2006; 42(2):91-7. PubMed ID: 16528124
[TBL] [Abstract][Full Text] [Related]
45. A randomized trial of diagnostic techniques for ventilator-associated pneumonia.
Canadian Critical Care Trials Group
N Engl J Med; 2006 Dec; 355(25):2619-30. PubMed ID: 17182987
[TBL] [Abstract][Full Text] [Related]
46. Incidence and Consequences of Near-Drowning-Related Pneumonia-A Descriptive Series from Martinique, French West Indies.
Cerland L; Mégarbane B; Kallel H; Brouste Y; Mehdaoui H; Resiere D
Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29149019
[TBL] [Abstract][Full Text] [Related]
47. [Treatment of aspiration pneumonia with piperacillin].
Ducroix JP; Tondriaux A; Smail A; Lobjoie E; Laurans G; Baillet J
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):530-2. PubMed ID: 2385450
[TBL] [Abstract][Full Text] [Related]
48. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients.
Mehta S; Burry L; Fischer S; Martinez-Motta JC; Hallett D; Bowman D; Wong C; Meade MO; Stewart TE; Cook DJ;
Crit Care Med; 2006 Feb; 34(2):374-80. PubMed ID: 16424717
[TBL] [Abstract][Full Text] [Related]
49. Empiric antimicrobial therapy in critical illness: results of a surgical infection society survey.
Aarts MA; Granton J; Cook DJ; Bohnen JM; Marshall JC
Surg Infect (Larchmt); 2007 Jun; 8(3):329-36. PubMed ID: 17635055
[TBL] [Abstract][Full Text] [Related]
50. Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia.
Ioanas M; Ferrer M; Cavalcanti M; Ferrer R; Ewig S; Filella X; de la Bellacasa JP; Torres A
Crit Care Med; 2004 Apr; 32(4):938-45. PubMed ID: 15071382
[TBL] [Abstract][Full Text] [Related]
51. The association between empiric antimicrobial therapy and the risk of clinical failure in critically ill patients with aspiration pneumonia.
Brumit JC; Cluck DB; Brown TP; Tharp JL
J Clin Pharm Ther; 2022 Nov; 47(11):1820-1825. PubMed ID: 36096493
[TBL] [Abstract][Full Text] [Related]
52. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital.
Warren MM; Gibb AP; Walsh TS
J Hosp Infect; 2005 Feb; 59(2):90-5. PubMed ID: 15620441
[TBL] [Abstract][Full Text] [Related]
53. Aspiration pneumonia.
Finegold SM
Rev Infect Dis; 1991; 13 Suppl 9():S737-42. PubMed ID: 1925318
[TBL] [Abstract][Full Text] [Related]
54. Incidence of anaerobic bacteria in patients with suspected pneumonia in surgical Intensive Care Unit.
Clavier T; Gouin P; Frebourg N; Rey N; Royon V; Bergis A; Hobeika S; Dureuil B; Veber B
Minerva Anestesiol; 2014 Oct; 80(10):1076-83. PubMed ID: 24472750
[TBL] [Abstract][Full Text] [Related]
55. [Treatment of community-acquired lung abscess associated with aspiration].
Ewig S; Schäfer H
Pneumologie; 2001 Sep; 55(9):431-7. PubMed ID: 11536067
[TBL] [Abstract][Full Text] [Related]
56. [Epidemiology of antibiotic resistance: implications for empirical treatment in intensive care].
Wolff M
Schweiz Med Wochenschr; 1995 Sep; 125(36):1684-6. PubMed ID: 7481623
[TBL] [Abstract][Full Text] [Related]
57. Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome.
Vidaur L; Gualis B; Rodriguez A; Ramírez R; Sandiumenge A; Sirgo G; Diaz E; Rello J
Crit Care Med; 2005 Jun; 33(6):1248-53. PubMed ID: 15942339
[TBL] [Abstract][Full Text] [Related]
58. Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia.
Llitjos JF; Amara M; Benzarti A; Lacave G; Bedos JP; Pangon B
J Crit Care; 2018 Feb; 43():375-377. PubMed ID: 29113712
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
[TBL] [Abstract][Full Text] [Related]
60. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
Kadowaki M; Demura Y; Mizuno S; Uesaka D; Ameshima S; Miyamori I; Ishizaki T
Chest; 2005 Apr; 127(4):1276-82. PubMed ID: 15821205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
